Clinic and genetic predictors in response to erenumab.

Chiara ZeccaSarah CargninChristoph SchankinNadia Mariagrazia GiannantoniMichele VianaIsabella MaraffiGianna Carla RiccitelliShairin SihabdeenSalvatore TerrazzinoClaudio Gobbi

Published in: European journal of neurology (2022)

In this real-word study, treatment with ERE significantly reduced MMDs. The number of failed preventive medications, migraine burden, and age at migraine onset predicted response to ERE. Larger studies are required to confirm a possible role of RAMP1 rs7590387 as genetic predictor of ERE efficacy.

Keyphrases

genome wide
primary care
copy number
smoking cessation